Ease of use, higher efficiency and lower risk of disease transmission in surgical applications ...
62% planning to invest in generative AI within the next three years, higher than global (56%)...
Company announces $100 Million in total funding from new and existing investors to advance medical innovation...
To provide early-stage AI startups with a unique platform...
Strategic partnership with Paradigm to leverage cutting-edge clinical trial platform technology...
Enhanced biosensing and connected health solutions...
To extend into hemodynamic and health mapping products...
To enhance the patient and staff experience with reduced X-ray dose, procedure time ...
Sale of intellectual property and commercial rights of its J-Valve System...
Study to focus on ability of implants to grow natural breast tissue and completely degrade over time...
